| Request a Trial to NEW EDGAR Online Pro Form 8-K for MEDICIS PHARMACEUTICAL CORP Completion of Acquisition or Disposition of Assets Item 2.01. Completion of Acquisition or Disposition of Assets. As previously reported, on June 16, 2008, Medicis Pharmaceutical Corporation ("Medicis") entered into a definitive merger agreement (the "Merger Agreement") with LipoSonix, Inc., a privately held Delaware corporation ("LipoSonix"). On July 1, 2008, Medicis closed its acquisition of LipoSonix and LipoSonix became a wholly-owned subsidiary of Medicis. Merger Consideration. All outstanding shares of LipoSonix's common stock and preferred stock, as well as all vested options, were converted into the right to receive at the closing an aggregate of $150 million in cash, subject to certain adjustments including the escrow fund described...
[read full story]